Related references
Note: Only part of the references are listed.Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols
Gunnar Cario et al.
HAEMATOLOGICA (2020)
A risk-stratified therapy for infants with acute lymphoblastic leukemia: a report from the JPLSG MLL-10 trial
Daisuke Tomizawa et al.
BLOOD (2020)
NUTM1 is a recurrent fusion gene partner in B-cell precursor acute lymphoblastic leukemia associated with increased expression of genes on chromosome band 10p12.31-12.2
Femke M. Hormann et al.
HAEMATOLOGICA (2019)
Clinical Pharmacokinetics and Pharmacodynamics of Nintedanib
Sven Wind et al.
CLINICAL PHARMACOKINETICS (2019)
Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study
Rob Pieters et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
A Simple RNA Target Capture NGS Strategy for Fusion Genes Assessment in the Diagnostics of Pediatric B-cell Acute Lymphoblastic Leukemia
Andrea Grioni et al.
HEMASPHERE (2019)
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000
Anja Moericke et al.
BLOOD (2016)
Profile of nintedanib in the treatment of solid tumors: the evidence to date
Niranjan Awasthi et al.
ONCOTARGETS AND THERAPY (2015)
LCK over-expression drives STAT5 oncogenic signaling in PAX5 translocated BCP-ALL patients
Valeria Cazzaniga et al.
ONCOTARGET (2015)
Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants
Ronald W. Stam et al.
BLOOD (2010)
Meis1 maintains stemness signature in MLL-AF9 leukemia
Ashish R. Kumar et al.
BLOOD (2010)
Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study
Valentino Conter et al.
BLOOD (2010)
The molecular biology of mixed lineage leukemia
Robert K. Slany
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
BIBF 1120: Triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy
Frank Hilberg et al.
CANCER RESEARCH (2008)
Acute lymphoblastic leukaemia
Ching-Hon Pui et al.
LANCET (2008)
Acute lymphoblastic leukemia in infancy
Lewis B. Silverman
PEDIATRIC BLOOD & CANCER (2007)
A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial
Rob Pieters et al.
LANCET (2007)
Molecular genetics of acute lymphoblastic leukemia
SA Armstrong et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Origins of chromosome translocations in childhood leukaemia
MF Greaves et al.
NATURE REVIEWS CANCER (2003)
Share Paper
